1. Home
  2. BTMD vs RSF Comparison

BTMD vs RSF Comparison

Compare BTMD & RSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biote Corp.

BTMD

Biote Corp.

HOLD

Current Price

$2.20

Market Cap

71.0M

Sector

Health Care

ML Signal

HOLD

Logo RiverNorth Capital and Income Fund

RSF

RiverNorth Capital and Income Fund

N/A

Current Price

$14.66

Market Cap

59.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BTMD
RSF
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.0M
59.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BTMD
RSF
Price
$2.20
$14.66
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$2.83
N/A
AVG Volume (30 Days)
404.5K
10.3K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
10.61%
EPS Growth
722.22
N/A
EPS
0.06
N/A
Revenue
$192,219,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$6.58
N/A
P/E Ratio
$33.17
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$14.23
52 Week High
$4.75
$15.07

Technical Indicators

Market Signals
Indicator
BTMD
RSF
Relative Strength Index (RSI) 53.69 52.02
Support Level $1.97 $14.58
Resistance Level $2.44 $14.73
Average True Range (ATR) 0.19 0.07
MACD -0.02 0.00
Stochastic Oscillator 64.37 55.53

Price Performance

Historical Comparison
BTMD
RSF

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

About RSF RiverNorth Capital and Income Fund

RiverNorth Capital and Income Fund is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income by investing in credit instruments, including a portfolio of securities of specialty finance and other financial companies.

Share on Social Networks: